Search Results 351-360 of 25576 for prostate cancer
Nilutamide is used with surgery to treat metastatic prostate cancer (cancer that has spread) in men. Nilutamide belongs to the group of medicines called ...
For the study, "Adjuvant Hormonal Therapy Does Not Adversely Impact Overall Survival Following Radical Prostatectomy for Men with High Risk Prostate Cancer When ...
Mayo Clinic researchers are using genetic sequencing to improve treatments for men with advanced prostate cancer. They're attempting to understand how tumors ...
... prostate cancer. Prostate Cancer Prostatic Dis. 2022 Sep; 25 (3):479-483 Epub 2021 July 22. View PubMed; Liu AJ, Kosiorek HE, Ueberroth BE, Jaeger E, Ledet E ...
the bladder, causing individuals to strain more to urinate. Dr. Cheney says prostate enlargement, or BPH, does not mean cancer. "It is truly just enlargement, ...
Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. · More about research at Mayo Clinic.
Treatments such as chemotherapy, hormone therapy and immunotherapy have had limited success against advanced prostate cancer due to the tumor's ability to ...
64Cu-SAR-bisPSMA And 67Cu-SAR-bisPSMA For Identification And Treatment Of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) · Overview.
Learn about this procedure used to treat urinary problems caused by an enlarged prostate gland.
... prostate cancer tissue. This will provide data that can be used to identify genetic marker profiles to diagnose and provide prognosis for prostate cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Send a note of thanks to Mayo Clinic researchers who are revolutionizing healthcare and improving patient outcomes.